Viewing Study NCT07037459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-01-25 @ 4:33 AM
Study NCT ID: NCT07037459
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2025-06-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure With Preserved Ejection Fraction View
None Heart Failure With Mildly Reduced Ejection Fraction View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Heart Failure View
None Obesity View
None Maridebart Cafraglutide View
None AMG 133 View
None MariTide View